siRNA treatment lowers triglycerides in patients along with uncommon ailment

.RESEARCH STUDY EMPHASIZE.19 September 2024. Plozasiran minimized triglyceride degrees by 80% and lowered the threat of pancreatitis in individuals along with constant chylomicronemia, with or without a genetic medical diagnosis.